NASDAQ
No price data available for this timeframe.
Atea Pharmaceuticals, Inc. (AVIR) has a current ratio of 7.82x as of Monday, May 25, 2026. This represents a 66.17% decrease compared to its 12-month average of 23.11x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.